3 Stocks to Buy With $10

Got $10? What if I say you can buy three contrarian stocks with this money and stand a chance to enjoy double-digit growth in a few years? 

| More on:

Do you know you can invest in stocks for as little as $10? These are called penny stocks. The problem with these stocks is they lack liquidity. So if you want to sell the stocks, your trade may not get executed quickly. But here I bring to you three high-volume Canadian stocks you can buy for just $10.5. 

Hive stock 

Hive Blockchain Technologies (TSXV:HIVE) stock is trading at $2.81 after falling 58% from its all-time high. It earns almost all its revenue from mining Bitcoin and Ethereum and selling them in the market for profit. It also earns revenue by hosting computing capacity to miners and by validating transactions on the blockchain. 

Hence, Hive stock is influenced by BTC and ETH prices. There are bull and bears around crypto. Every time crypto starts gaining momentum, regulators crackdown on the digital currency and ban its mining and trading to control money laundering. But that is a process every new revolution has to undergo.

What is interesting is the BTC momentum is gradually gaining acceptance. Not only the BTC bulls but also the top brass are coming to accept BTC. 

You may argue that the 2020-2021 BTC bubble has burst, but BTC value has surged significantly from the April 2018 bubble burst. Even Hive’s stock price has surged 77% from its April 2018 burst. This is the right time to buy the stock. It will keep falling until China’s regulatory crackdown eases.

But this stock will surge another 800-1,000% when the next crypto wave comes. What makes me so sure? In every crypto wave, BTC will take the centre stage because its supply is limited. 

Bombardier stock

Hive is a stock to hold for the long term, but I can’t say the same about Bombardier (TSX:BBD.B). The business jet maker has surged 170% year-to-date to $1.27 on the back of a recovery rally. For those who don’t know the history of Bombardier, its downfall began in 2013 after a product failure. Its products are so expensive that there is no room for error. 

One failure pushed Bombardier into multi-year losses and rising debt. Even a bailout and sale of its passenger plane and train business couldn’t bring the company back to profits. The company has downsized to a business jet maker and is seeing the return of demand as the pandemic-induced travel restrictions ease.

A 170% rally is too quick as the company is still years from profit. However, the stock is garnering increasing short interest in the derivatives market. I have a hunch that it could be a perfect prey for Redditors’ short squeeze game. If my hunch is correct, you could see the stock double in a week or two.

If not, you can wait and watch if the management succeeds in getting the company out of the debt trap this time. However, I have little hope for that unless the board makes management changes. 

Transat A.T. 

While Bombardier has already climbed the recovery wall, Transat A.T. (TSX:TRZ) has just started climbing, trading at $6.4. The tour operator was at risk of near bankruptcy after its acquisition by Air Canada met a dead-end in early April because of regulatory concerns. Transat stock dipped 22% in 45 days. 

Transat worries eased after the Canadian government approved a $700 million bailout package that was way more than $500 million needed to avert bankruptcy. The new funding and the easing of travel restrictions have revived hope for the tour operator sending the stock up 48% from its May low. While analysts are bearish on the stock because of its losses, I am optimistic. 

Many U.S. airlines are seeing the return of air travel demand to the pre-pandemic level, and most of this demand is from leisure travellers. There is pent-up demand for holiday travel, and Transat dominates most holiday destination routes between Canada and Europe. AC, therefore, wanted to buy Transat even when the former was burning cash. Transat stock could see a recovery rally in the second half. 

Fool contributor Puja Tayal has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

Quantum Computing Words on Digital Circuitry
Tech Stocks

Investors: Canada’s Government Is Backing Quantum Computing

Here’s what the Canadian government’s major new investment in quantum computing means for investors.

Read more »

top TSX stocks to buy
Tech Stocks

As the TSX Breaks Higher, These Canadian Stocks Look Poised to Win in 2026

Three Canadian stocks with high-velocity growth potential could be among TSX’s winning investments in 2026.

Read more »

warehouse worker takes inventory in storage room
Tech Stocks

Outlook for Shopify Stock in 2026

Shopify has delivered another strong year, but the bigger question now is whether its expanding platform and AI push can…

Read more »

AI concept person in profile
Tech Stocks

TFSA Wealth Plan: Create $1 Million With a Single Canadian Stock

Topicus could help build a $1 million TFSA thanks to sticky software, recurring revenue, and a disciplined acquisition engine if…

Read more »

AI image of a face with chips
Tech Stocks

The Market Sold BlackBerry After Its Earnings Beat – Here’s Why I’d Buy More

BlackBerry (TSX:BB) beat expectations again, yet the stock slipped, and a closer look at its latest numbers shows why that…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

These 2 TSX Stocks Look Set to Soar in 2026 and Beyond

2 TSX stocks to buy for 2026: MDA Space (MDA) offers deep value with a massive backlog, while Descartes Systems…

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

1 Dividend-Paying Tech Stock I’d Buy Before Touching Shopify

Constellation Software (TSX:CSU) might be a better value than other Canadian tech stars in 2026.

Read more »

doctor uses telehealth
Tech Stocks

Ready for Healthcare AI? Put WELL Health Technologies Plus 2 More on Your Watchlist

Three Canadian companies are sound investment options as AI adoption in the healthcare sector accelerates.

Read more »